New Delhi, April 24 -- To strengthen drug quality assurance, research collaboration and pharmacovigilance, the Indian Pharmacopoeia Commission (IPC) has signed two Memoranda of Understanding (MoUs) with the Pharmaceuticals & Medical Devices Bureau of India (PMBI) and the National Institute of Pharmaceutical Education and Research (NIPER), Hajipur.

The Ministry of Health and Family Welfare says the MoU between IPC and PMBI aims to enhance the quality assurance framework for medicines distributed through Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs). Under the agreement, PMBI may submit randomly selected batches of Jan Aushadhi medicines to IPC for quality testing.

The collaboration will also promote the use of the National Formula...